Latest Angiotensin II receptor antagonists Stories
MUMBAI and BALTIMORE, January 6, 2015 /PRNewswire/ -- Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc.
PITTSBURGH, Jan. 5, 2015 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the U.S.
CHAPEL HILL, N.C., Nov. 14, 2014 /PRNewswire/ -- In 1997, Novartis launched its antihypertension treatment Diovan into a crowded marketplace.
WOODCLIFF LAKE, N.J., Sept. 30, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc.
Dr. Milton Packer and Dr. McMurray will be presenting these results for the first time in the United States at the HFSA Annual Meeting LAS VEGAS, Sept.
DUBLIN, Sept. 9, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the U.S.
Receives first-to-file FDA approval, with 180-day marketing exclusivity for generic version in the treatment of hypertension and heart failure NEW BRUNSWICK, N.J., June 27, 2014 /PRNewswire/
OTTAWA, May 23, 2014 /CNW/ - The issue: Pharmascience Inc., in consultation with Health Canada, is recalling one lot of PMS-Losartan-HCTZ due to a labelling error on the blister
DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/skgh5l/investigation) has announced the addition of the "Investigation
ChinaMarketResearchReports.com adds Latest Report on “Investigation Report on China Valsartan Market, 2009-2018” to its store. Dallas, TX (PRWEB) February
- A poem in which the author retracts something said in an earlier poem.